Back to Results
First PageMeta Content



November 21, 2016 U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the
Add to Reading List

Document Date: 2016-11-21 07:45:02


Open Document

File Size: 40,45 KB

Share Result on Facebook
UPDATE